ArticleChemSusChem2026
An Integrated Engineering Approach to Intensify the Biocatalytic Metaraminol Synthesis.
Article in ChemSusChem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An Integrated Engineering Approach to Intensify the Biocatalytic Metaraminol Synthesis.ChemSusChem · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metaraminol is a chiral amino alcohol and plays an important role as a precursor molecule and active pharmaceutical ingredient in industry. Its enzymatic synthesis has been developed in recent years and can serve as an alternative to conventional synthesis routes that use toxic, fossil-based resources. Although the enzymatic two-step reaction toward metaraminol has been intensively investigated in the past, full conversion has never been reached in the amine transaminase-catalyzed step. In this study, we focus on identifying and overcoming the hurdles of the transamination step to reach higher metaraminol yields. Photometric and LC-MS analyses revealed side-product formation as a major drawback for the enzymatic metaraminol synthesis. Besides the oxidation of (R)-3-OH-PAC as well as its imine formation with isopropylamine, we demonstrate for the first time the adduct formation of the cofactor pyridoxal-5'-phosphate with metaraminol. Only by changing the amine transaminase formulation to purified enzyme and increasing the concentration by tenfold, >99% product yield with a metaraminol concentration of 75 mM was reached. Further, we successfully integrated the amine donor l-alanine by applying a continuous product extraction system as an alternative to isopropylamine. We believe that our findings and optimization strategies can also serve as a blueprint for other amine-based syntheses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.